Registry for patients with myocardial infarction and non-obstructive coronary arteries

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry collects clinical data on patients diagnosed with myocardial infarction with non-obstructive coronary arteries (MINOCA) at Barts Health NHS Trust. It aims to understand the characteristics and outcomes of these patients, who represent a challenging group for treatment due to the lack of clear management guidelines. The study utilizes a prospectively collected database, ensuring that all patient data is anonymized and only accessible to the research team. Patients are included based on their clinical presentations, and the registry will continue indefinitely as part of routine clinical care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Both male and female patients ≥16 years of age will be included
* All patients will have a diagnosis MINOCA. Any patient who does not have a clear cause of troponin rise

Exclusion Criteria:

* Patients \<16 years will not be included in this study.

Where it's running

• Barts Health NHS Trust
  London, United Kingdom Recruiting

Study contacts

• Principal investigator: Daniel Jones, MBBS, PhD — Queen Mary University of London
• Study coordinator: Daniel Jones, MBBS, PhD
• Email: dan.jones8@nhs.net
• Phone: 020 7377 7000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Heart@Home: Safe, at-home care for people with acute heart problems compared with hospital care

  This trial tests whether hospital-level care at home can safely and effectively treat adults with acute heart conditions who would normally be in the hospital.

  Recruiting Tel-Aviv Sourasky Medical Center · Tel Aviv · NCT07913152

• Digital cardiac rehab to help heart attack patients improve function

  A digital health–supported cardiac rehabilitation program is being tested to see if it helps people after a heart attack improve fitness and stay engaged with rehab, compared with standard outpatient rehab.

  Recruiting Cairo University · Minya, Minya Province · NCT07867197

• NMR-based Risk Test and Digital Health Support for midlife adults in Eloisa

  This study tests whether an NMR metabolomics risk test can guide tailored digital health programs for midlife adults at risk of diabetes, heart disease, stroke, kidney disease, or fatty liver.

  Recruiting University of Eastern Finland · Savonlinna · NCT07820800

• See if stopping long-term aspirin is as good as continuing it in older adults with stable ischemic heart disease

  In adults 65 and older with stable ischemic heart disease, this trial tests whether stopping daily low-dose aspirin is not worse than continuing it.

  Recruiting at 2 sites Phase 4 Odense University Hospital · Copenhagen and 1 other locations · NCT07795398

• Innate Immune Cells and Early Fibrotic Repair After a Heart Attack

  This study tests whether specific neutrophil and monocyte patterns are linked to early scar formation after a heart attack in STEMI patients.

  Recruiting Shanghai 10th People's Hospital · Shanghai · NCT07764588

• AI-assisted gender prediction from the jawbone using CBCT measurements

  A retrospective study tests whether AI can predict a person’s gender from measurements of the mandible taken from existing CBCT scans.

  Recruiting Cairo University · Cairo · NCT07726290

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.